4
Changes in Ownership
AEON Biopharma, Inc. Filed Acc 0001104659-23-083565
Director acquired 15,627 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
FISCHER JOST · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-21 | Grant or award : show line 1 in the form | +13,274 | 13,274 | D |
| 2023-07-21 | Grant or award : show line 2 in the form | +2,353 | 2,353 | D |
Table II: Derivative
6 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-21 | Grant or award : show line 3 in the form Stock Option | +21,974 | 21,974 | D |
| 2023-07-21 | Grant or award : show line 4 in the form Stock Option | +19,800 | 19,800 | D |
| 2023-07-21 | Grant or award : show line 5 in the form Stock Option | +21,198 | 12,198 | D |
| 2023-07-21 | Grant or award : show line 6 in the form Restricted Stock Units | +19,286 | 19,286 | D |
| 2023-07-21 | Grant or award : show line 7 in the form Restricted Stock Units | +6,289 | 6,289 | D |
| 2023-07-21 | Grant or award : show line 8 in the form Restricted Stock Units | +35,189 | 35,189 | D |
Loading xslF345X05/tm2321918-8_4seq1.xml…